CMPX vs FFIV · $367.4M cap vs P/E 32, rev $3.09B
Compass Therapeutics Inc. (CMPX) versus F5 Networks Inc (FFIV) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
CMPX does not have a complete income-statement cache yet.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. Revenue was up 9.7% from 2024-09-30 to 2025-09-30. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
CMPX currently screens at market cap $367.4M. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
Not investment advice. Open the CMPX and FFIV stock pages for the full models.
Not investment advice.